person · Reporting owner

BRANDT ERIC

Disclosed activity across 7 companies

Tapewire entity: 10671
SEC CIK: 0001190639

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
DENTSPLY SIRONA Inc.XRAY · Entity 4448	Director	April 12, 2024	April 15, 2024
Gen Digital Inc.GEN · Entity 2098	Director	September 09, 2026	September 11, 2026
LAM RESEARCH CORPLRCX · Entity 1467	Director	June 12, 2026	June 15, 2026
MACERICH COMAC · Entity 3712	Director	May 30, 2024	June 04, 2024
Nutanix, Inc.NTNX · Entity 3296	Director	December 12, 2025	December 17, 2025
Option Care Health, Inc.OPCH · Entity 4126	Director	May 20, 2026	May 22, 2026
VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875	Director	January 29, 2009	January 30, 2009

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

DENTSPLY SIRONA Inc.

Report date April 12, 2024 · Filed April 15, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	53,372.146	Reported balance After 2024-04-12 transaction · row 2 1 source row Row 2 · 2024-04-12 · Grant · Acquired 72.546 · Balance 53,372.146 F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
Phantom Stock (Directors' Deferred Compensation) DDCSEC Table II · derivative / convertible security	Direct	1,543.4018	Reported balance After 2024-04-12 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2024-04-12 · Grant · Acquired 7.8111 · Balance 1,543.4018 F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3: Comprised of phantom stock acquired as a result of accrued dividends.
Common StockSEC Table I · non-derivative	IndirectBy The Brandt Family Trust U/a Dtd 06/09/2006	5,400	Reported balance Holding disclosure · report date 2024-04-12 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 5,400

Filing footnotes · ownership attribution and instrument terms

F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director.

F3: Comprised of phantom stock acquired as a result of accrued dividends.

Gen Digital Inc.

Report date September 09, 2026 · Filed September 11, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	9,072	Ending reported balance After 2026-09-09 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-09-09 · Grant · Acquired 9,072 · Balance 17,894 F1: Annual non-employee director equity award. The RSUs will vest 100% on the earlier of September 9, 2027, or the next annual meeting, and subject to service through the respective vesting date. Row 2 · 2026-09-09 · Gift · Disposed 8,822 · Balance 9,072 F2: Stock transfer to family trust over which the reporting person has voting power.
Common StockSEC Table I · non-derivative	IndirectThe Brandt Family Trust	78,506	Reported balance After 2026-09-09 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2026-09-09 · Gift · Acquired 8,822 · Balance 78,506

Filing footnotes · ownership attribution and instrument terms

F1: Annual non-employee director equity award. The RSUs will vest 100% on the earlier of September 9, 2027, or the next annual meeting, and subject to service through the respective vesting date.

F2: Stock transfer to family trust over which the reporting person has voting power.

LAM RESEARCH CORP

Report date June 12, 2026 · Filed June 15, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	144,705	Last balance in matching sequence After 2026-06-12 transaction · row 17 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 17 source rows Row 1 · 2026-06-12 · Sale · Disposed 300 · Balance 198,905 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $355.39 to $356.02, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 2 · 2026-06-12 · Sale · Disposed 1,393 · Balance 197,512 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $356.685 to $357.67, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 3 · 2026-06-12 · Sale · Disposed 1,100 · Balance 196,412 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F5: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $357.68 to $358.35, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 4 · 2026-06-12 · Sale · Disposed 3,828 · Balance 192,584 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F6: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $358.73 to $359.54, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 5 · 2026-06-12 · Sale · Disposed 1,906 · Balance 190,678 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F7: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $359.84 to $360.79, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 6 · 2026-06-12 · Sale · Disposed 819 · Balance 189,859 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F8: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $360.85 to $361.83, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 7 · 2026-06-12 · Sale · Disposed 2,708 · Balance 187,151 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F9: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $361.87 to $362.82, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 8 · 2026-06-12 · Sale · Disposed 2,345 · Balance 184,806 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F10: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $363.77, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 9 · 2026-06-12 · Sale · Disposed 2,300 · Balance 182,506 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F11: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $364.85, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 10 · 2026-06-12 · Sale · Disposed 1,200 · Balance 181,306 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F12: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $364.98 to $365.67, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 11 · 2026-06-12 · Sale · Disposed 5,803 · Balance 175,503 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F13: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $366.56 to $367.55, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 12 · 2026-06-12 · Sale · Disposed 4,030 · Balance 171,473 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F14: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $367.62 to $368.49, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 13 · 2026-06-12 · Sale · Disposed 4,198 · Balance 167,275 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F15: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.70 to $369.64, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 14 · 2026-06-12 · Sale · Disposed 5,037 · Balance 162,238 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F16: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $369.70 to $370.69, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 15 · 2026-06-12 · Sale · Disposed 8,233 · Balance 154,005 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F17: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $370.70 to $371.59, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 16 · 2026-06-12 · Sale · Disposed 7,700 · Balance 146,305 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F18: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $371.77 to $372.76, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 17 · 2026-06-12 · Sale · Disposed 1,600 · Balance 144,705 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F19: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $372.79 to $373.36, inclusive F3: The amount reported includes shares subject to unvested restricted stock units.

Filing footnotes · ownership attribution and instrument terms

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $355.39 to $356.02, inclusive

F3: The amount reported includes shares subject to unvested restricted stock units.

F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $356.685 to $357.67, inclusive

F5: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $357.68 to $358.35, inclusive

F6: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $358.73 to $359.54, inclusive

F7: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $359.84 to $360.79, inclusive

F8: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $360.85 to $361.83, inclusive

F9: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $361.87 to $362.82, inclusive

F10: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $363.77, inclusive

F11: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $364.85, inclusive

F12: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $364.98 to $365.67, inclusive

F13: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $366.56 to $367.55, inclusive

F14: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $367.62 to $368.49, inclusive

F15: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.70 to $369.64, inclusive

F16: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $369.70 to $370.69, inclusive

F17: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $370.70 to $371.59, inclusive

F18: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $371.77 to $372.76, inclusive

F19: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $372.79 to $373.36, inclusive

MACERICH CO

Report date May 30, 2024 · Filed June 04, 2024 · Amendment

Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	62,978	Reported balance Holding disclosure · report date 2024-05-30 · row 1 Amendment: may correct only part of an earlier disclosure. 1 source row Row 1 · Balance 62,978

Nutanix, Inc.

Report date December 12, 2025 · Filed December 17, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	6,698	Reported balance After 2025-12-12 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2025-12-12 · Grant · Acquired 4,588 · Balance 6,698 F1: Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. F2: The amount reported includes 4,588 unvested RSUs, which are issuable into shares of the Issuer's Class A common stock upon vesting.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock.

F2: The amount reported includes 4,588 unvested RSUs, which are issuable into shares of the Issuer's Class A common stock upon vesting.

Option Care Health, Inc.

Report date May 20, 2026 · Filed May 22, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	21,999	Ending reported balance After 2026-05-20 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-05-20 · Grant · Acquired 8,997 · Balance 19,356 F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026. Row 2 · 2026-05-20 · Grant · Acquired 2,643 · Balance 21,999 F2: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.

F2: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.

VERTEX PHARMACEUTICALS INC / MA

Report date January 29, 2009 · Filed January 30, 2009

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Ending reported balance After 2009-01-29 transaction · row 3 3 source rows · reconciled sequence Row 1 · 2009-01-29 · Exercise / conversion · Acquired 20,000 · Balance 20,000 Row 2 · 2009-01-29 · Exercise / conversion · Acquired 7,500 · Balance 27,500 Row 3 · 2009-01-29 · Sale · Disposed 27,500 · Balance 0 F1: Transaction made pursuant to Mr. Brandt's company approved trading plan under Rule 10b5-1.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $13.22 · Expires 2013-05-20	Direct	Reported balance After 2009-01-29 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2009-01-29 · Exercise / conversion · Disposed 20,000 · Balance 0 F2: Fully vested.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $9.09 · Expires 2015-05-31	Direct	Reported balance After 2009-01-29 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2009-01-29 · Exercise / conversion · Disposed 7,500 · Balance 0 F2: Fully vested.

Filing footnotes · ownership attribution and instrument terms

F1: Transaction made pursuant to Mr. Brandt's company approved trading plan under Rule 10b5-1.

F2: Fully vested.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
December 12, 2025 Filed Dec 17, 2025 00:07 UTC	Nutanix, Inc. NTNX · Entity 3296	GrantClass A Common Stock	4,588	$0.00	$0.00	Disclosure SEC source: 0001193125-25-321302 · ownership.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,698 F1 · shares: Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. F2 · balance_after: The amount reported includes 4,588 unvested RSUs, which are issuable into shares of the Issuer's Class A common stock upon vesting. Read SEC document
November 07, 2025 Filed Nov 10, 2025 18:06 UTC	LAM RESEARCH CORP LRCX · Entity 1467	GrantCommon Stock	1,635	$0.00	$0.00	Disclosure SEC source: 0001190639-25-000004 · wk-form4_1762798013.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,705 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
September 09, 2025 Filed Sep 11, 2025 20:25 UTC	Gen Digital Inc. GEN · Entity 2098	GiftCommon Stock	10,038	$0.00	$0.00	Disclosure SEC source: 0000849399-25-000074 · wk-form4_1757622327.xml · nonDerivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · The Brandt Family Trust Disclosed balance after: 69,684 F2 · shares: Stock transfer to family trust over which the reporting person has voting power. Read SEC document
September 09, 2025 Filed Sep 11, 2025 20:25 UTC	Gen Digital Inc. GEN · Entity 2098	GiftCommon Stock	10,038	$0.00	$0.00	Disclosure SEC source: 0000849399-25-000074 · wk-form4_1757622327.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,822 F2 · shares: Stock transfer to family trust over which the reporting person has voting power. Read SEC document
September 09, 2025 Filed Sep 11, 2025 20:25 UTC	Gen Digital Inc. GEN · Entity 2098	GrantCommon Stock	8,822	$0.00	$0.00	Disclosure SEC source: 0000849399-25-000074 · wk-form4_1757622327.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,860 F1 · shares: Annual non-employee director equity award. The RSUs will vest 100% on the earlier of September 9, 2026, or the next annual meeting, and subject to service through the respective vesting date. Read SEC document
May 15, 2025 Filed May 16, 2025 20:30 UTC	Nutanix, Inc. NTNX · Entity 3296	GrantClass A Common Stock	2,110	$0.00	$0.00	Disclosure SEC source: 0000950170-25-073615 · ownership.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,110 F1 · shares: Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. F2 · balance_after: The amount reported consists of the unvested RSUs referenced in footnote (1), which are issuable into shares of the Issuer's Class A common stock upon vesting. Read SEC document
May 14, 2025 Filed May 19, 2025 22:23 UTC	Option Care Health, Inc. OPCH · Entity 4126	GrantCommon Stock	5,034	$0.00	$0.00	Disclosure SEC source: 0001437749-25-017667 · rdgdoc.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,359 F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document
November 08, 2024 Filed Nov 12, 2024 16:25 UTC	LAM RESEARCH CORP LRCX · Entity 1467	GrantCommon Stock	2,950	$0.00	$0.00	Disclosure SEC source: 0000707549-24-000146 · wk-form4_1731428698.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,070 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
September 12, 2024 Filed Sep 13, 2024 20:17 UTC	Gen Digital Inc. GEN · Entity 2098	GiftCommon Stock	13,340	$0.00	$0.00	Disclosure SEC source: 0000849399-24-000074 · wk-form4_1726258648.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · The Brandt Family Trust Disclosed balance after: 59,646 F1 · shares: Stock transfer to family trust for which the reporting person remains a beneficial owner and exercises voting and dispositive power. Read SEC document
September 12, 2024 Filed Sep 13, 2024 20:17 UTC	Gen Digital Inc. GEN · Entity 2098	GiftCommon Stock	13,340	$0.00	$0.00	Disclosure SEC source: 0000849399-24-000074 · wk-form4_1726258648.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,038 F1 · shares: Stock transfer to family trust for which the reporting person remains a beneficial owner and exercises voting and dispositive power. Read SEC document
September 10, 2024 Filed Sep 12, 2024 20:42 UTC	Gen Digital Inc. GEN · Entity 2098	GrantCommon Stock	10,038	$0.00	$0.00	Disclosure SEC source: 0000849399-24-000058 · wk-form4_1726173758.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,378 F1 · shares: Annual non-employee director equity award. The RSUs will vest 100% on the earlier of September 10, 2025, or the next annual meeting, and subject to service through the respective vesting date. Read SEC document
May 30, 2024 Filed Jun 3, 2024 21:29 UTC	MACERICH CO MAC · Entity 3712	GrantCommon Stock	9,103	$0.00	$0.00	Disclosure SEC source: 0000912242-24-000095 · wk-form4_1717450138.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,978 F1 · shares: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan ("2003 Plan"). The restricted stock units vest one year after the award date. Read SEC document
May 15, 2024 Filed May 17, 2024 23:15 UTC	Option Care Health, Inc. OPCH · Entity 4126	GrantCommon Stock	5,325	$0.00	$0.00	Disclosure SEC source: 0001437749-24-017539 · rdgdoc.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,325 F1 · shares: The reporting person received an award of restricted stock units on May 15, 2024, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 15, 2024. Read SEC document
April 12, 2024 Filed Apr 15, 2024 23:08 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative	7.8111	$31.45	$245.66	Disclosure SEC source: 0001127602-24-012895 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,543.4018 Underlying: Common Stock · 7.8111 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document
April 12, 2024 Filed Apr 15, 2024 23:08 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	72.546	$0.00	$0.00	Disclosure SEC source: 0001127602-24-012895 · form4.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,372.146 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document
January 12, 2024 Filed Jan 16, 2024 18:41 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative	5.8203	$36.80	$214.19	Disclosure SEC source: 0001127602-24-001305 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,535.5907 Underlying: Common Stock · 5.8203 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document
January 12, 2024 Filed Jan 16, 2024 18:41 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	58.964	$0.00	$0.00	Disclosure SEC source: 0001127602-24-001305 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,275.6 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document
November 17, 2023 Filed Nov 20, 2023 20:23 UTC	LAM RESEARCH CORP LRCX · Entity 1467	GiftCommon Stock	72	$0.00	$0.00	Disclosure SEC source: 0000707549-23-000150 · wk-form4_1700511776.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,412 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
November 10, 2023 Filed Nov 13, 2023 17:51 UTC	LAM RESEARCH CORP LRCX · Entity 1467	GrantCommon Stock	369	$0.00	$0.00	Disclosure SEC source: 0000707549-23-000140 · wk-form4_1699897888.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,484 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
October 13, 2023 Filed Oct 16, 2023 20:42 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative	6.9422	$30.71	$213.19	Disclosure SEC source: 0001127602-23-025905 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,529.7704 Underlying: Common Stock · 6.9422 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document
October 13, 2023 Filed Oct 16, 2023 20:42 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	100.847	$0.00	$0.00	Disclosure SEC source: 0001127602-23-025905 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,216.636 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document
September 12, 2023 Filed Sep 14, 2023 21:30 UTC	Gen Digital Inc. GEN · Entity 2098	OtherCommon Stock	11,970	$0.00	$0.00	Disclosure SEC source: 0001209191-23-049466 · doc4.xml · nonDerivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Brandt Family Trust Disclosed balance after: 46,306 F3 · shares: Stock transfer from the reporting person Read SEC document
September 12, 2023 Filed Sep 14, 2023 21:30 UTC	Gen Digital Inc. GEN · Entity 2098	GrantCommon Stock	13,340	$0.00	$0.00	Disclosure SEC source: 0001209191-23-049466 · doc4.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,340 F2 · shares: Annual non-employee director equity award. This restricted stock unit will fully vest on the earlier of September 12, 2024, or the next annual meeting. Read SEC document
September 12, 2023 Filed Sep 14, 2023 21:30 UTC	Gen Digital Inc. GEN · Entity 2098	OtherCommon Stock	11,970	$0.00	$0.00	Disclosure SEC source: 0001209191-23-049466 · doc4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Stock transfer to family trust over which the reporting person has voting power. Read SEC document
July 14, 2023 Filed Jul 17, 2023 20:51 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative	5.1646	$41.14	$212.47	Disclosure SEC source: 0001127602-23-020821 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,522.8282 Underlying: Common Stock · 5.1646 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document
July 14, 2023 Filed Jul 17, 2023 20:51 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	85.781	$0.00	$0.00	Disclosure SEC source: 0001127602-23-020821 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,115.789 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document
May 31, 2023 Filed Jun 2, 2023 22:44 UTC	MACERICH CO MAC · Entity 3712	GrantCommon Stock	14,004	$0.00	$0.00	Disclosure SEC source: 0001209191-23-034005 · doc4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,875 F1 · shares: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan. The restricted stock units vest one year after the award. Read SEC document
May 25, 2023 Filed May 26, 2023 20:40 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	8,128	$0.00	$0.00	Disclosure SEC source: 0001127602-23-016968 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,030.008 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document
May 02, 2023 Filed May 3, 2023 20:41 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	Exercise / conversionStock Option (Right to Buy) · Derivative	6,200	$0.00 Strike: $41.47	$0.00	Disclosure SEC source: 0001127602-23-014286 · form4.xml · derivative · entry 4 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,200 shares Expires 2023-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document
May 02, 2023 Filed May 3, 2023 20:41 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	SaleCommon Stock	6,200	$42.17	$261,454.00	Disclosure SEC source: 0001127602-23-014286 · form4.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,902.008 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on March 10, 2021, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Read SEC document
May 02, 2023 Filed May 3, 2023 20:41 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	Exercise / conversionCommon Stock	6,200	$41.47	$257,114.00	Disclosure SEC source: 0001127602-23-014286 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,102.008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
April 14, 2023 Filed Apr 18, 2023 20:29 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative	5.1513	$41.11	$211.77	Disclosure SEC source: 0001127602-23-013126 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,517.6636 Underlying: Common Stock · 5.1513 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock and accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document
April 14, 2023 Filed Apr 18, 2023 20:29 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	58.221	$0.00	$0.00	Disclosure SEC source: 0001127602-23-013126 · form4.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,902.008 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document
January 13, 2023 Filed Jan 17, 2023 17:03 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative	5.2029	$36.21	$188.40	Disclosure SEC source: 0001127602-23-001446 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,512.5123 Underlying: Common Stock · 5.2029 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document
January 13, 2023 Filed Jan 17, 2023 17:03 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	63.879	$0.00	$0.00	Disclosure SEC source: 0001127602-23-001446 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,843.787 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document
November 15, 2022 Filed Nov 16, 2022 21:17 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	9,573	$0.00	$0.00	Disclosure SEC source: 0001127602-22-025755 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,779.908 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document
November 11, 2022 Filed Nov 14, 2022 19:14 UTC	LAM RESEARCH CORP LRCX · Entity 1467	GrantCommon Stock	563	$0.00	$0.00	Disclosure SEC source: 0000707549-22-000134 · wf-form4_166845326490297.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,115 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
October 25, 2022 Filed Nov 14, 2022 19:14 UTC	LAM RESEARCH CORP LRCX · Entity 1467	GiftCommon Stock	300	$0.00	$0.00	Disclosure SEC source: 0000707549-22-000134 · wf-form4_166845326490297.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,552 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
October 14, 2022 Filed Oct 18, 2022 20:25 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative	6.4437	$29.11	$187.58	Disclosure SEC source: 0001127602-22-024085 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,507.3094 Underlying: Common Stock · 6.4437 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document
October 14, 2022 Filed Oct 18, 2022 20:25 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	29.404	$0.00	$0.00	Disclosure SEC source: 0001127602-22-024085 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,206.908 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document
September 13, 2022 Filed Sep 15, 2022 21:20 UTC	Gen Digital Inc. NLOK · Entity 2098	GrantCommon Stock	5,010	$0.00	$0.00	Disclosure SEC source: 0001209191-22-050109 · doc4.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Brandt Family Trust Disclosed balance after: 46,306 F2 · shares: In connection with the reporting person's service as a non-employee director of the Issuer for the period between April 2, 2022 and September 13, 2022, such reporting person has been granted restricted stock units. 100% of the restricted stock units vested on the grant date. Read SEC document
September 13, 2022 Filed Sep 15, 2022 21:20 UTC	Gen Digital Inc. NLOK · Entity 2098	GrantCommon Stock	11,970	$0.00	$0.00	Disclosure SEC source: 0001209191-22-050109 · doc4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Brandt Family Trust Disclosed balance after: 41,296 F1 · shares: In connection with the reporting person's service as a non-employee director of the Issuer for the period between September 13, 2022 and September 12, 2023, pursuant to the non-employee director grant policy, such reporting person has been granted restricted stock units. 100% of the restricted stock units will vest on the first year anniversary of the grant date. Read SEC document
September 13, 2022 Filed Sep 24, 2022 01:28 UTC Amendment	Gen Digital Inc. NLOK · Entity 2098	GrantCommon Stock	5,010	$0.00	$0.00	Disclosure SEC source: 0001209191-22-051199 · doc4a.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Brandt Family Trust Disclosed balance after: 34,336 F2 · balance_after: Awards issued pursuant to the 2013 Employee Incentive Plan, as amended. F3 · balance_after: Prorated director retainer fee and annual director awards granted in stock for the period between April 2 and September 12, 2022. The restricted stock units vested 100% on grant date. Read SEC document
September 13, 2022 Filed Sep 24, 2022 01:28 UTC Amendment	Gen Digital Inc. NLOK · Entity 2098	GrantCommon Stock	11,970	$0.00	$0.00	Disclosure SEC source: 0001209191-22-051199 · doc4a.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,970 F1 · balance_after: Annual director award granted pursuant to the non-employee director compensation policy. This restricted stock units will vest 100% on the first anniversary of the grant date. F2 · balance_after: Awards issued pursuant to the 2013 Employee Incentive Plan, as amended. Read SEC document
July 08, 2022 Filed Jul 11, 2022 20:33 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantPhantom Stock (Directors' Deferred Compensation) DDC · Derivative	5.263	$35.52	$186.94	Disclosure SEC source: 0001127602-22-019183 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500.8657 Underlying: Common Stock · 5.263 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document
July 08, 2022 Filed Jul 11, 2022 20:33 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	22.6	$0.00	$0.00	Disclosure SEC source: 0001127602-22-019183 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,177.504 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document
May 27, 2022 Filed Jun 1, 2022 22:28 UTC	MACERICH CO MAC · Entity 3712	GrantCommon Stock	11,421	$0.00	$0.00	Disclosure SEC source: 0001209191-22-033289 · doc4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,871 F1 · shares: Non-cash compensation - Award of restricted stock units under The Macerich Company 2003 Equity Incentive Plan. The restricted stock units vest one year after the award. Read SEC document
May 03, 2022 Filed May 4, 2022 23:44 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	Exercise / conversionStock Option (Right to Buy) · Derivative	6,900	$0.00 Strike: $38.02	$0.00	Disclosure SEC source: 0001127602-22-013340 · form4.xml · derivative · entry 4 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,900 shares Expires 2022-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document
May 03, 2022 Filed May 4, 2022 23:44 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	SaleCommon Stock	6,900	$39.71	$273,999.00	Disclosure SEC source: 0001127602-22-013340 · form4.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,154.904 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person. Read SEC document
May 03, 2022 Filed May 4, 2022 23:44 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	Exercise / conversionCommon Stock	6,900	$38.02	$262,338.00	Disclosure SEC source: 0001127602-22-013340 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,054.904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.